Heart failure patients may skip some office visits with new remote monitoring
NCT ID NCT07544771
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a remote monitoring system called HeartLogic to standard in-person follow-up for people with heart failure who have a special defibrillator. About 578 adults will be randomly assigned to either get alerts from the device that prompt early check-ins or to continue regular office visits. The goal is to see if remote monitoring reduces deaths, unplanned hospital stays, and declines in quality of life over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HeartLogic algorithm (remote monitoring device software)
What this could lead to
If it works, this could make heart failure management more proactive, reducing hospital stays and improving daily life for patients.
What could go wrong
This is a mid-sized trial (578 people) testing a monitoring strategy, not a new drug. The benefit may be small or not apply to all patients, and false alerts could cause unnecessary worry or visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Georges Pompidou European hospital
NOT_YET_RECRUITINGParis, France
Contact
-
Hopital du Confluent
NOT_YET_RECRUITINGNantes, France
Contact Phone: •••-•••-••••
-
La Pitié Salpétrière
NOT_YET_RECRUITINGParis, France
Contact
-
La Timone University hospital
NOT_YET_RECRUITINGMarseille, France
Contact
-
Pasteur clinic
NOT_YET_RECRUITINGToulouse, France
Contact
-
University hospital of Amiens
NOT_YET_RECRUITINGAmiens, France
Contact
-
University hospital of Brest
NOT_YET_RECRUITINGBrest, France
Contact Phone: •••-•••-••••
-
University hospital of Caen
NOT_YET_RECRUITINGCaen, France
Contact
-
University hospital of Grenoble
NOT_YET_RECRUITINGGrenoble, France
Contact
-
University hospital of Lille
NOT_YET_RECRUITINGLille, France
Contact
-
University hospital of Nantes
NOT_YET_RECRUITINGNantes, France
Contact Phone: •••-•••-••••
-
University hospital of Poitiers
RECRUITINGPoitiers, 86021, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University hospital of Rouen
NOT_YET_RECRUITINGRouen, France
Contact
-
University hospital of Toulouse
NOT_YET_RECRUITINGToulouse, France
Contact
-
University hospital of Tours
NOT_YET_RECRUITINGTours, France
Contact